ENEA Tech e Biomedical investe in Approxima Srl, startup MedTech innovativa impegnata nello sviluppo di una tecnologia percutanea di rimodellamento del ventricolo destro per il trattamento dell'insufficienza tricuspidale.
The global burden of disease is growing at an exponential rate, with healthcare systems increasingly struggling to provide the care that patients with chronic and rare diseases or cancer need.
Health is shaped by many interconnected factors, so transforming health can only come through working in an interconnected way. Diverse minds, perspectives, and skills are brought together in our dynamic internal teams and collaborations inside and outside of our industry.
Facility will support discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
Collaboration leverages the Cellectis gene editing technologies and manufacturing capabilities, to develop up to 10 novel cell and gene therapy candidate products.
Novavax condividerà con il Bill & Melinda Gates Medical Research Institute un ingrediente chiave del suo vaccino anti-Covid e di altri in fase di sviluppo per potenziare nuovi vaccini contro malaria e tubercolosi. L’accordo tra le due società durerà tre anni e prevede che il Gates Mri possa usare l’adiuvante Matrix-M*, un composto che potenzia la risposta del sistema immunitario, nella ricerca preclinica.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
